申请人:UBE Industries, Ltd.
公开号:EP3309163A1
公开(公告)日:2018-04-18
The present invention provides a compound represented by the general formula (Ia) or a pharmacologically acceptable salt thereof. In the general formula (Ia), two R moieties each independently represent a C1-3 alkyl group or the like; and R1, R2 and R3 each independently represent an optionally substituted linear or branched C1-4 alkyl group.
本发明提供了通式(Ia)所代表的化合物或其药理学上可接受的盐。在通式(Ia)中,两个 R 子各自独立地代表一个 C1-3 烷基或类似物;R1、R2 和 R3 各自独立地代表一个任选取代的直链或支链 C1-4 烷基。